Thursday, 16 October 2025
  
Login

Australia's most trusted
source of pharma news

Thursday, 16 October 2025
News

'Essential' drug finally hits TGA

Posted 16 October 2025 AM

Two new drugs are on their way to Australia, along with new indications for two more, including one on the World Health Organisation's (WHO) list of essential medicines.

Viatris has received two orphan drug designations for pretomanid, a tuberculosis treatment that is marketed overseas under the brand name Dovprela. One indication is in combination with bedaquiline, linezolid, and moxifloxacin for the treatment of adults with pulmonary tuberculosis (TB) due to Mycobacterium tuberculosis resistant to rifampicin, with or without resistance to isoniazid, while the second leaves out moxifloxacin to treat disease that is also resistant to fluoroequinolones such as moxifloxacin.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (26)

Clinical & Medical, R&D (8)

Regulatory, Pharmacovigilance & QA (1)

Devices (1)

Other (14)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.